{"disease":{"id":"impaired-hypoglycemic-awareness","name":"impaired hypoglycemic awareness"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04786262","title":"A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":52,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":false},{"nct_id":"NCT07126873","title":"A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":21,"lead_sponsor_name":"EndoCell Therapeutics, Inc.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}